Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523985 | SCV000619871 | pathogenic | not provided | 2017-08-11 | criteria provided, single submitter | clinical testing | The c.962_964delTAG variant in the DDX3X gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant causes an in-frame deletion of codon Valine 321, denoted p.Val321del. The c.962_964delTAG variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The deleted amino acid is a residue that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, we interpret c.962_964delTAG as a pathogenic variant. |
Ambry Genetics | RCV001267128 | SCV001445309 | uncertain significance | Inborn genetic diseases | 2019-07-24 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001706658 | SCV001934275 | likely pathogenic | Intellectual disability, X-linked 102 | 2020-10-27 | criteria provided, single submitter | clinical testing | Criteria applied: PS2, PS4_SUP, PM4_SUP, PM2_SUP |
Molecular Genetics Lab, |
RCV001706658 | SCV004697677 | uncertain significance | Intellectual disability, X-linked 102 | criteria provided, single submitter | clinical testing |